Advanced Medical Solutions Group (LON:AMS) Earns Sector Perform Rating from Royal Bank Of Canada

Key Points

• Royal Bank of Canada reissued a "sector perform" on Advanced Medical Solutions (LON:AMS) with a GBX 260 price target (implying ~28.1% upside), while Berenberg reaffirmed a GBX 300 "buy" target; consensus is a "Moderate Buy" (three Buys, one Hold) with an average target of GBX 270.25.
• Shares opened at GBX 203 (market cap £439.3m) and trade at a high valuation (P/E ~44.9); the company posted quarterly EPS of GBX 11.98 and shows modest profitability (ROE 3.87%, net margin 4.35%) with a one‑year range of GBX 168.40–248.50.

Advanced Medical Solutions Group (LON:AMS - Get Free Report)'s stock had its "sector perform" rating reissued by equities researchers at Royal Bank Of Canada in a report released on Thursday,London Stock Exchange reports. They presently have a GBX 260 price objective on the stock. Royal Bank Of Canada's price objective would suggest a potential upside of 28.08% from the stock's previous close.

Separately, Berenberg Bank reissued a "buy" rating and set a GBX 300 target price on shares of Advanced Medical Solutions Group in a research report on Wednesday, March 18th. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, Advanced Medical Solutions Group has an average rating of "Moderate Buy" and an average price target of GBX 270.25.

Advanced Medical Solutions Group Price Performance

Shares of AMS opened at GBX 203 on Thursday. The stock has a market capitalization of £439.30 million, a price-to-earnings ratio of 44.91, a price-to-earnings-growth ratio of 5.00 and a beta of 0.63. Advanced Medical Solutions Group has a 1 year low of GBX 168.40 and a 1 year high of GBX 248.50. The business's 50 day simple moving average is GBX 204.95 and its 200-day simple moving average is GBX 213.13. The company has a debt-to-equity ratio of 31.50, a current ratio of 2.79 and a quick ratio of 4.58.

Advanced Medical Solutions Group (LON:AMS - Get Free Report) last issued its quarterly earnings data on Wednesday, March 18th. The company reported GBX 11.98 earnings per share (EPS) for the quarter. Advanced Medical Solutions Group had a return on equity of 3.87% and a net margin of 4.35%. As a group, equities analysts expect that Advanced Medical Solutions Group will post 9.8159509 earnings per share for the current fiscal year.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.